JP2014169285A5 - - Google Patents

Download PDF

Info

Publication number
JP2014169285A5
JP2014169285A5 JP2014019893A JP2014019893A JP2014169285A5 JP 2014169285 A5 JP2014169285 A5 JP 2014169285A5 JP 2014019893 A JP2014019893 A JP 2014019893A JP 2014019893 A JP2014019893 A JP 2014019893A JP 2014169285 A5 JP2014169285 A5 JP 2014169285A5
Authority
JP
Japan
Prior art keywords
production example
dimethyl
iodophenyl
trifluoromethyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014019893A
Other languages
English (en)
Japanese (ja)
Other versions
JP5799117B2 (ja
JP2014169285A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014019893A priority Critical patent/JP5799117B2/ja
Priority claimed from JP2014019893A external-priority patent/JP5799117B2/ja
Publication of JP2014169285A publication Critical patent/JP2014169285A/ja
Publication of JP2014169285A5 publication Critical patent/JP2014169285A5/ja
Application granted granted Critical
Publication of JP5799117B2 publication Critical patent/JP5799117B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014019893A 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬 Expired - Fee Related JP5799117B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014019893A JP5799117B2 (ja) 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013020426 2013-02-05
JP2013020426 2013-02-05
JP2014019893A JP5799117B2 (ja) 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬

Publications (3)

Publication Number Publication Date
JP2014169285A JP2014169285A (ja) 2014-09-18
JP2014169285A5 true JP2014169285A5 (cg-RX-API-DMAC7.html) 2015-04-30
JP5799117B2 JP5799117B2 (ja) 2015-10-21

Family

ID=51691962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014019893A Expired - Fee Related JP5799117B2 (ja) 2013-02-05 2014-02-05 ウラシル誘導体からなる医薬

Country Status (1)

Country Link
JP (1) JP5799117B2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6990663B2 (ja) * 2016-05-31 2022-01-13 シエッシ ファーマスーティシ エス.ピー.エー. ヒト好中球エラスターゼ阻害剤としてのイミダゾロン化合物
CA3026983A1 (en) * 2016-06-08 2017-12-14 Glaxosmithkline Intellectual Property Development Limited Chemical compounds
EP3787612A4 (en) 2018-05-04 2021-11-17 Remedy Plan, Inc. CANCER TREATMENTS AGAINST CANCER STEM CELLS
PH12022551081A1 (en) 2019-11-06 2024-06-19 Remedy Plan Inc Cancer treatments targeting cancer stem cells
GB201918414D0 (en) 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
ES2970315T3 (es) * 2020-07-31 2024-05-28 Abarceo Pharma Ab Nuevos inhibidores del VDAC1
WO2023033097A1 (ja) * 2021-09-02 2023-03-09 Eaファーマ株式会社 複素環スルホンアミド誘導体の製造方法、およびその合成中間体
CN113952359A (zh) * 2021-11-19 2022-01-21 大连理工大学盘锦产业技术研究院 顺铂与Tri-1的联合抗肺癌药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
JP5709999B2 (ja) * 2011-08-01 2015-04-30 大日本住友製薬株式会社 ウラシル誘導体およびその医薬用途

Similar Documents

Publication Publication Date Title
US10501465B2 (en) Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors
DE602004010206T2 (de) Dipeptidyl Peptidase Inhibitoren.
RU2682672C2 (ru) Соединения дигидропиримидина и их применение в фармацевтических препаратах
AU2020407200A1 (en) Irak degraders and uses thereof
JP5869338B2 (ja) タンパク質キナーゼ阻害剤
JP5366968B2 (ja) Dna中のg−四重鎖領域と相互作用するナフタレンジイミド化合物
US8084466B2 (en) Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
CY1111651T1 (el) Παραγωγα 3-(ετεροαρυλ-oξυ)-2-αλκυλ-1-αζα- δικυκλοαλκυλιου ως συνδετες του αλφα.7-nachr για τη θεραπεια των ασθενειων του κνς
WO2021158634A1 (en) Irak degraders and uses thereof
JP2022536092A5 (cg-RX-API-DMAC7.html)
US9518055B2 (en) Imidazopyridyl compounds as aldosterone synthase inhibitors
KR20190130129A (ko) 벤조디아제핀 유도체의 제조 방법
US20160264567A1 (en) Substituted sulfonamide compounds
CN103328468A (zh) 用于治疗疼痛、精神障碍、认知损害或阿尔茨海默病的α-7烟碱型受体调节剂
TW200634015A (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
JP2009500329A (ja) アミノ−5−(6員)ヘテロアリールイミダゾロン化合物およびβ−セレクターゼ調節のためのその使用
JP2009532424A (ja) ドーパミンd3受容体のモジュレーターとしてのアザビシクロ[3.1.0]ヘキシル誘導体
US10875848B2 (en) Inhibiting fatty acid synthase (FASN)
JP2006519868A5 (cg-RX-API-DMAC7.html)
JP2018534243A5 (cg-RX-API-DMAC7.html)
WO2026090477A1 (en) Helicase inhibitors and uses thereof
US10202401B2 (en) Process for making tetracyclic heterocycle compounds
EP3134406A1 (en) Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo [4,3-c]pyridine compounds as glyt1 inhibitors
UA88795C2 (ru) Гетероциклические соединения, которые применяются для лечения воспалителных и аллергических нарушений
CN105272921A (zh) 一种制备Ceritinib的方法及其中间体化合物